, Tracking Stock Market Picks
Enter Symbol:
Isis Pharmaceuticals, Inc. (ISIS) [hlAlert]

up 187.88 %

Isis Pharmaceuticals, Inc. (ISIS) rated Buy with price target $28 by Cantor Fitzgerald

Posted on: Wednesday,  Jul 29, 2009  8:25 AM ET by Cantor Fitzgerald

Cantor Fitzgerald rated Buy Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) on 07/29/2009, when the stock price was $17.91. Since
then, Isis Pharmaceuticals, Inc. has gained 187.88% as of 11/10/2015's recent price of $51.56.
If you would have followed this Cantor Fitzgerald's recommendation on ISIS, you would have gained 187.88% of your investment in 2295 days.

Isis Pharmaceuticals, Inc. (Isis) is engaged in antisense technology, exploiting a drug discovery platform to create a pipeline of drugs. The Company operates in a two principal segments: Drug Discovery and Development and Regulus Therapeutics Inc. Within the Drug Discovery and Development segment, its drug discovery platform enables the Company to identify drugs, providing potential targets to treat a range of diseases. As of December 31, 2008, the Company has 19 drugs in development. Its partners are licensed to develop, with the Company?s support, 15 of these 19 drugs. The Company and Alnylam established Regulus Therapeutics Inc. as a company focused on the discovery, development and commercialization of microRNA therapeutics. In January 2009, the Company sold its subsidiary, Ibis Biosciences, Inc. to Abbott Molecular Inc. (AMI), a wholly owned subsidiary of Abbott Laboratories.

Cantor U.S. Equity Research provides timely and insightful opinions on select stocks. We look at key drivers of the stock price, including company and industry fundamentals, capital markets influences and overall economic trends to provide critical and in-depth analysis. Our focus is on small and mid-cap companies in the following sectors: * Marine Transportation * Life Sciences * Clean Technology & Energy Efficiency * Real Estate * Communications Technology * Internet * Enterprise Software
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/29/2009 8:25 AM Buy
17.91 28.00
as of 12/31/2009
1 Week down  -17.15 %
1 Month down  -13.44 %
3 Months down  -36.37 %
1 YTD down  -48.24 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy